Holen Sie sich die Stockscreener-App
5.205
4.41%
-0.235
Schlusskurs vom Vortag:
$5.44
Offen:
$5.44
24-Stunden-Volumen:
24,305
Relative Volume:
0.16
Marktkapitalisierung:
$69.00M
Einnahmen:
$52.29M
Nettoeinkommen (Verlust:
$-73.52M
KGV:
-7.8864
EPS:
-0.66
Netto-Cashflow:
$-100.45M
1W Leistung:
+1.96%
1M Leistung:
-36.27%
6M Leistung:
+7.66%
1J Leistung:
-28.67%
1-Tages-Spanne:
$5.12
$5.535
1-Wochen-Bereich:
$4.8601
$5.535
52-Wochen-Spanne:
$3.61
$8.82
Precision Biosciences Inc Stock (DTIL) Company Profile
Firmenname
Precision Biosciences Inc
Sektor
Branche
Telefon
919-314-5512
Adresse
302 EAST PETTIGREW STREET, DURHAM, NC
Vergleichen Sie DTIL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
5.205 | 130.95M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.09 | 110.02B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
763.72 | 82.00B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
457.43 | 59.61B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
887.80 | 56.15B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.51 | 44.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | Eingeleitet | Guggenheim | Buy |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-06-09 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | Fortgesetzt | BTIG Research | Buy |
| 2020-04-03 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Stifel | Buy |
| 2020-02-25 | Eingeleitet | William Blair | Outperform |
| 2019-08-09 | Eingeleitet | BTIG Research | Buy |
| 2019-07-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-04-22 | Eingeleitet | Barclays | Overweight |
| 2019-04-22 | Eingeleitet | Goldman | Buy |
| 2019-04-22 | Eingeleitet | JP Morgan | Overweight |
| 2019-04-22 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Precision Biosciences Inc Aktie (DTIL) Neueste Nachrichten
How Precision BioSciences Inc. stock compares to industry benchmarksJuly 2025 Levels & Daily Momentum Trading Reports - BỘ NỘI VỤ
Will Precision BioSciences Inc. stock outperform Nasdaq indexJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - moha.gov.vn
United StatesMintz Advises On Precision BioSciences, Inc.’s $75 Million Registered Direct Offering - Mondaq
H.C. Wainwright Keeps Their Buy Rating on Precision BioSciences (DTIL) - The Globe and Mail
Will Precision BioSciences Inc. stock return to pre crisis levelsLayoff News & Growth Focused Stock Reports - newser.com
Detecting price anomalies in Precision BioSciences Inc. with AIFed Meeting & Technical Confirmation Alerts - newser.com
How analysts rate Precision BioSciences Inc. stock todayMarket Sentiment Report & High Accuracy Swing Entry Alerts - newser.com
Will Precision BioSciences Inc. stock outperform Dow Jones indexAnalyst Downgrade & Weekly Top Gainers Alerts - newser.com
Will Precision BioSciences Inc. (PBS0) stock beat revenue estimates2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com
Mintz Advises on Precision BioSciences, Inc.’s $75 Million Registered Direct Offering - Mintz
Precision BioSciences (DTIL) Price Target Decreased by 10.55% to 33.15 - MSN
How Precision BioSciences Inc. (PBS0) stock compares with market leaders2025 Momentum Check & Daily Stock Trend Reports - newser.com
Is Precision BioSciences Inc. stock dividend yield sustainableWeekly Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Is Precision BioSciences Inc. (PBS0) stock a contrarian opportunity2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
Precision BioSciences Inc. (DTIL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why pension funds invest in Precision BioSciences Inc. (PBS0) stock2025 Retail Activity & High Return Stock Watch Alerts - newser.com
Precision BioSciences (Nasdaq: DTIL) to Present PBGENE-HBV Trial Data at Hep-DART 2025 - Stock Titan
Precision BioSciences Announces Presentation of Clinical Data from the ELIMINATE-B Trial at HEP-DART 2025 - Business Wire
Is Precision BioSciences Inc. (PBS0) stock in buy zone after pullback - newser.com
Genome Editing Market Research Report 2025-2032Industry - openPR.com
How hedge fund analytics apply to Precision BioSciences Inc. stock2025 Big Picture & Scalable Portfolio Growth Ideas - newser.com
Multi asset correlation models including Precision BioSciences Inc.July 2025 Market Mood & High Accuracy Trade Signal Alerts - newser.com
Can Precision BioSciences Inc. stock resist market sell offsJuly 2025 Opening Moves & Intraday High Probability Alerts - newser.com
Is Precision BioSciences Inc. stock positioned well for digital economy2025 Pullback Review & Weekly Market Pulse Alerts - newser.com
Real time breakdown of Precision BioSciences Inc. stock performanceIndex Update & Accurate Entry/Exit Alerts - newser.com
Has Precision BioSciences Inc. found a price floorPortfolio Value Report & Reliable Price Breakout Alerts - newser.com
Finanzdaten der Precision Biosciences Inc-Aktie (DTIL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Precision Biosciences Inc-Aktie (DTIL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kelly John Alexander | Chief Financial Officer |
Nov 03 '25 |
Sale |
6.49 |
1,303 |
8,456 |
77,298 |
| Scimeca Dario | General Counsel and Secretary |
Nov 02 '25 |
Option Exercise |
0.00 |
1,835 |
0 |
28,923 |
| Scimeca Dario | General Counsel and Secretary |
Nov 03 '25 |
Sale |
6.49 |
665 |
4,316 |
28,258 |
| Amoroso Michael | President and CEO |
Nov 02 '25 |
Option Exercise |
0.00 |
9,444 |
0 |
118,984 |
| Amoroso Michael | President and CEO |
Nov 03 '25 |
Sale |
6.49 |
3,409 |
22,124 |
115,575 |
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):